Related Experiment Video
Updated: Aug 23, 2025

14:20
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.8K
Advanced MXene-Based Micro- and Nanosystems for Targeted Drug Delivery in Cancer Therapy
Fatemeh Mohajer1, Ghodsi Mohammadi Ziarani1, Alireza Badiei2
1Department of Organic Chemistry, Faculty of Chemistry, Alzahra University, Tehran 19938-93973, Iran.
Micromachines
|October 27, 2022
Summary
MXenes show promise for targeted cancer drug delivery due to their unique properties. Further research is needed to overcome challenges in pharmacokinetics, biosafety, and clinical translation for effective cancer therapy.
Area of Science:
- Materials Science
- Nanotechnology
- Biomedical Engineering
Background:
- MXenes, 2D materials with unique properties like high conductivity and biocompatibility, are explored for cancer therapy.
- Their photothermal effects, biocompatibility, and luminescence make them attractive for drug delivery systems.
- Challenges remain in optimizing MXene-based systems for clinical applications.
Purpose of the Study:
- To review recent advances in MXene-based targeted drug delivery systems for cancer therapy.
- To highlight the challenges and future directions in this research area.
- To encourage further investigation into MXene applications in oncology.
Main Methods:
- Literature review of MXene synthesis and functionalization for drug delivery.
- Analysis of MXene properties relevant to cancer therapy (photothermal, optical, electronic).
- Discussion of pharmacokinetic, biosafety, and targeting aspects of MXene-based systems.
Main Results:
- MXenes offer tunable properties for enhanced drug loading and release.
- Demonstrated potential for photothermal therapy and imaging-guided drug delivery.
- Identified key challenges including controlled functionalization and in vivo performance.
Conclusions:
- MXenes hold significant potential for developing advanced targeted drug delivery systems in cancer therapy.
- Addressing challenges in pharmacokinetics, biosafety, and clinical translation is crucial for realizing their full potential.
- Continued research is essential to optimize MXene-based nanomedicines for effective cancer treatment.

